|
π
|
MiR-34a Targeting of Notch Ligand Delta-Like 1 Impairs CD15+/CD133+ Tumor-Propagating Cells and Supports Neural Differentiation in Medulloblastoma
19 auth.
Pasqualino de Antonellis,
Chiara Medaglia,
E. Cusanelli,
I. Andolfo,
L. Liguori,
Gennaro De Vita,
M. Carotenuto,
A. Bello,
F. Formiggini,
A. Galeone,
...
G. De Rosa,
A. Virgilio,
Immacolata Scognamiglio,
Manuela Sciro,
G. Basso,
J. Schulte,
G. Cinalli,
A. Iolascon,
M. Zollo
|
7 |
2011 |
7
π
|
|
π
|
Upregulation of miR-21 by Ras in vivo and its role in tumor growth
14 auth.
D. Frezzetti,
M. D. Menna,
P. Zoppoli,
C. Guerra,
A. Ferraro,
A. Bello,
P. D. Luca,
C. Calabrese,
A. Fusco,
M. Ceccarelli,
...
M. Zollo,
M. Barbacid,
R. Lauro,
G. D. Vita
|
7 |
2011 |
7
π
|
|
π
|
Dipyridamole prevents triple-negative breast-cancer progression
13 auth.
D. Spano,
J. Marshall,
Natascia Marino,
D. Martino,
Alessia Romano,
M. N. Scoppettuolo,
A. Bello,
Valeria Di Dato,
L. Navas,
G. Vita,
...
Chiara Medaglia,
P. Steeg,
M. Zollo
|
5 |
2012 |
5
π
|
|
π
|
H-Prune through GSK-3Ξ² interaction sustains canonical WNT/Ξ²-catenin signaling enhancing cancer progression in NSCLC
22 auth.
M. Carotenuto,
Pasqualino de Antonellis,
L. Liguori,
G. Benvenuto,
Daniela Magliulo,
A. Alonzi,
C. Turino,
Carmela Attanasio,
Valentina Damiani,
A. Bello,
...
F. Vitiello,
R. Pasquinelli,
L. Terracciano,
A. Federico,
A. Fusco,
J. Freeman,
T. Dale,
C. Decraene,
G. Chiappetta,
F. Piantedosi,
C. Calabrese,
M. Zollo
|
5 |
2014 |
5
π
|
|
π¬
|
CXCL12 Signaling in the Tumor Microenvironment.
L. Portella,
A. Bello,
S. Scala
|
5 |
2021 |
5
π¬
|
|
π
|
PRUNE and NM23-M1 expression in embryonic and adult mouse brain
7 auth.
P. Carotenuto,
Natascia Marino,
A. Bello,
A. D'Angelo,
U. Porzio,
D. Lombardi,
...
M. Zollo
|
5 |
2006 |
5
π
|
|
π
|
Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection
10 auth.
A. Ottaiano,
S. Scala,
C. DβAlterio,
A. Trotta,
A. Bello,
Giuseppina Rea,
...
Carmine Picone,
M. Santorsola,
A. Petrillo,
G. Nasti
|
4 |
2021 |
4
π
|
|
π
|
Detection of high mobility group A2 specific mRNA in the plasma of patients affected by epithelial ovarian cancer
14 auth.
F. Galdiero,
A. Romano,
R. Pasquinelli,
S. Pignata,
S. Greggi,
E. Vuttariello,
A. Bello,
C. Calise,
C. Scaffa,
C. Pisano,
...
N. Losito,
A. Fusco,
D. Califano,
G. Chiappetta
|
4 |
2015 |
4
π
|
|
π
|
Ovarian Cancer Translational Activity of the Multicenter Italian Trial in Ovarian Cancer (MITO) Group: Lessons Learned in 10 Years of Experience
18 auth.
D. Califano,
D. Russo,
G. Scognamiglio,
N. Losito,
A. Spina,
A. Bello,
Anna Capiluongo,
F. Galdiero,
R. De Cecio,
S. Bevilacqua,
...
P. Gargiulo,
E. Marchesi,
S. Canevari,
F. Perrone,
G. Daniele,
L. De Cecco,
D. Mezzanzanica,
S. Pignata
|
3 |
2020 |
3
π
|
